文献速递胸部肿瘤

国际肺癌研究协会肺癌分期项目:关于第九版肺癌TNM分类中T描述符修订的建议

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2023-12-07

国际肺癌研究协会利用124,581例肺癌患者数据库分析T描述符,其中33,982例纳入临床T分析、30,715例纳入病理术后分析。存活分析显示第八版T描述符在第九版数据集中表现充分;病理胸壁或壁层胸膜受累(PL 3)生存差于其他T3描述符且与T4肿瘤相似,但临床胸壁或PL 3肿瘤未见此差异。因结果不一致,不建议重新分配胸壁或PL 3肿瘤,T分委员会提议第九版不做任何更改、保留当前第八版T描述符。

要点

  • 第八版T描述符在第九版数据集中表现充分。
  • 病理胸壁或PL 3肿瘤生存与T4相似,但临床胸壁或PL 3肿瘤未见此差异。
  • T分委员会提议第九版保留第八版T描述符,不做更改。

核心结论

  • T分委员会成员提议不实施任何更改,第九版保留当前第八版T描述符。

研究设计与样本

  • 国际肺癌研究协会建立国际数据库,纳入2011年1月1日至2019年12月31日诊断的124,581例肺癌患者。
  • 其中33,982例符合临床T分析纳入标准,30,715例符合病理术后分析纳入标准。
  • 临床分期肿瘤从诊断日期起测量生存,病理分期肿瘤从手术日期起测量生存。
  • T描述符经单变量分析和校正年龄、性别、病理类型及地理区域的多变量Cox回归分析评估。

主要发现

  • 综合存活分析显示,现有第八版T组分标准在第九版数据集中表现充分。
  • 病理胸壁或壁层胸膜受累(PL 3)生存差于其他T3描述符,与T4肿瘤生存相似,但临床胸壁或PL 3肿瘤未见此差异。
  • 因上述结果不一致,不建议重新分配胸壁或PL 3肿瘤。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: An international database was created by the International Association for the Study of Lung Cancer to inform on the ninth edition of the TNM classification of lung cancer. The present analyses concern its T component. METHODS: Data on 124,581 patients diagnosed with lung cancer from January 1, 2011 to December 31, 2019 were submitted to the International Association for the Study of Lung Cancer database. Of these, 33,982 met the inclusion criteria for the clinical T analysis, and 30,715 met the inclusion criteria for the pathologic postsurgical analysis. Survival was measured from the date of diagnosis or operation for clinically and pathologically staged tumors, respectively. T descriptors were evaluated in univariate analysis and multivariable Cox regression analysis adjusted for age, sex, pathologic type, and geographic region. RESULTS: Comprehensive survival analysis revealed that the existing eighth edition T component criteria performed adequately in the ninth edition data set. Although pathologic chest wall or parietal pleura involvement (PL 3) yielded a worse survival compared with the other T3 descriptors, with a similar survival as T4 tumors, this difference was not observed for clinical chest wall or PL 3 tumors. Because of these inconsistent findings, no reallocation of chest wall or PL 3 tumors is advised. CONCLUSIONS: The T subcommittee members proposed not to implement any changes and keep the current eighth-edition T descriptors for the ninth edition.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Van Schil PE, Asamura H, Nishimura KK, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2023. PMID: 38070600. doi:10.1016/j.jtho.2023.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。